- Inquiries for EVIO’s cannabis testing services have skyrocketed since California’s regulatory changes were announced
- EVIO is poised to be a cannabis testing leader in California and is prepared to meet the increased demand for testing services
- New EVIO cannabis testing facilities are on track to open in Los Angeles and Humboldt County, California, by fall 2018
California cannabis vendors and distributors have been scrambling to make the July 1 deadline set forth by the California state government, mandating that all products found on marijuana dispensary shelves after that date must meet new testing standards relating to pesticides and residual solvents found in cannabis products. Under the new regulations, any untested or non-compliant cannabis products can no longer be sold by retailers; instead, they must either be destroyed or returned to distributors. Violators not in compliance after the deadline could face fines and other penalties.
While cannabis merchants and distributors have been sweating the deadline, leading cannabis testing provider EVIO Inc. (OTCQB: EVIO) has been as cool as a cucumber, having prepared for months for the impending changes and to accommodate the increased demand for cannabis testing services that’s sure to accompany them (http://cnw.fm/uyO6V).
A flood of inquiries has inundated EVIO since the changes were announced, with high-profile cannabis distributors from across the Golden State contacting the company about its state-of-the-art cannabis testing services. The overall number of potential clients with whom EVIO has been discussing contracts has skyrocketed.
Through its EVIO Labs division, EVIO provides cutting-edge accredited cannabis testing and analysis services, as well as scientific research and a full array of consulting services, for the regulated cannabis industry, helping its clients meet state regulatory mandates and be prepared for success in every area of their business. EVIO’s overarching aim is to ensure the safety and quality of the cannabis supply in the United States.
In the past, EVIO’s California facilities were testing cannabis products for 21 pesticides. Now, in keeping with the new regulations, the company will test for 66 pesticides.
The company’s EVIO Labs Berkeley just recently attained ISO 17025 accreditation, which is the world’s highest recognized quality standard for calibration and testing laboratories, and it is ready to perform California’s July 1st new testing regulations.
EVIO has also been working to expand its overall footprint in California. In May, the company signed a lease for a 2,700-square-foot facility in Los Angeles, and EVIO also acquired Leaf Detective, LLC, in April, which was the very first licensed cannabis testing facility in Humboldt County, California. The strategic acquisition of Leaf Detective gave EVIO a foothold within the “Emerald Triangle,” which is the biggest cannabis-producing region in the U.S. The Los Angeles and Humboldt County facilities are scheduled to open in the fall of 2018, and EVIO plans to further expand its operational growth in California and to add more personnel going forward.
EVIO is well-positioned to become a standout leader in the independent cannabis testing laboratory space, and, as California’s July 1 deadline looms, the company is unquestionably poised to take a leadership position in that state.
In other developments, EVIO recently announced the addition of technology industry expert Donald R. Gibbs, CPA, CMA, to its board of directors to serve as independent director and chair of the company’s audit committee (http://cnw.fm/PP0Vg).
For more information, visit the company’s website at www.EVIOLabs.com
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com